Peer-influenced content. Sources you trust. No registration required. This is HCN.

Oncology Nurse AdvisorDigital Patient Navigation Platform Fosters Engagement Between Physicans and Patients with Melanoma

ℹ️ Observational Association Only Evidence

Researchers at Johns Hopkins evaluated a digital patient navigation platform (DPNP) designed to bridge information gaps and referral barriers for melanoma patients across academic and regional health system settings. Clickthrough rates of 30%–41% and conversion rates of 23%–25% exceeded established web-based healthcare messaging benchmarks of 7% and 10%, respectively.


Clinical Considerations

  • The DPNP identified and invited patients with recent melanoma diagnoses via EHR-based portal messaging, flagging those without multidisciplinary care for outreach; 8 of 559 invited patients were classified high-risk (stage II or higher) and warranted subspecialty consultation
  • Engagement exceeded benchmarks at both sites, but transition to multidisciplinary care occurred more reliably at the academic center than at regional health systems, suggesting setting-specific barriers persist even when digital access improves
  • Median geographic distance for regional health system registrants was 100 miles, underscoring the access gap this type of platform targets
  • Data are from a conference poster presentation and have not yet undergone peer review; findings should be interpreted as an early feasibility signal

Practice Applications

  • Recognize DPNP tools as an emerging care coordination mechanism for connecting melanoma patients to cutaneous oncology subspecialists and clinical trials
  • Consider that digital navigation platforms may support NP/PA roles in identifying patients who have not yet received multidisciplinary evaluation
  • Monitor for peer-reviewed publication and expanded outcome data before integrating DPNP models into formal referral workflows
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form